CONNIE KLOTZBACH: Open Payments
NPI 1225576820 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,226 in 231 payments from 32 companies in 2025. Trend: 2023 $2,938 · 2024 $3,857 · 2025 $4,226
Food & beverage: $4,193Education: $33
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $751 |
| UCB, Inc. | 19 | $374 |
| Alexion Pharmaceuticals, Inc. | 12 | $255 |
| ACADIA Pharmaceuticals Inc | 16 | $239 |
| Neurocrine BioSciences, Inc. | 8 | $206 |
| Novartis Pharmaceuticals Corporation | 9 | $195 |
| PFIZER INC. | 15 | $184 |
| Amgen Inc. | 6 | $166 |
| SK Life Science, Inc. | 6 | $156 |
| Teva Pharmaceuticals USA, Inc. | 10 | $154 |
Products named: BOTOX, QULIPTA, ULTOMIRIS, NUPLAZID, INGREZZA, KESIMPTA, Zilbrysq, NURTEC ODT.
Industry payments across MS — which companies pay providers there.
